Severe Community-Acquired Pneumonia research hub

An Exploratory, Multi-Centre, Interventional, Prospective, Randomised, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of AON-D21 in Patients with Severe Community-Acquired Pneumonia.

This study is testing a new medicine, AON-D21, for people with severe pneumonia. Researchers want to see if it's safe and effective, and to understand any side effects. Half the patients will get the medicine, and half will get a dummy treatment, to compare results.